
















In this column, Sharon Rees aims to refresh knowledge and interest in some of the  
commonly used drugs in a series of tweets. This month she is talking about #haloperidol
Dr Sharon Rees @reesprescribe 
Day 1: Haloperidol was discovered mid-50s, as derived from 
chemical modification to opioids ie pethidine; found to have 
anti-psychotic effects, but no analgesia. Main uses include 
schizophrenia, manic episodes associated bipolar disorder, tic 
disorders such as Tourette’s, anti-emetic post-op/palliative
Dr Sharon Rees @reesprescribe 
Day 1 (cont): #haloperidol can be used in children for 
adolescent schizophrenia, rapid treatment of aggression  
and tic syndrome. UK unlicensed use in palliative care
Dr Sharon Rees @reesprescribe 
Day 2: Anti-psychotic adult dose range #haloperidol 2-10 mg/
day in divided doses; some conditions such as aggression, 
tic disorder 0.5-5 mg. NOTE: lower doses elderly e.g start half 
adult dose and typically max 5 mg/day. Children dose range 
lower/variable depends on age and (sometimes) weight
Dr Sharon Rees @reesprescribe 
Day 2 (cont): #haloperidol: i.m & s.c infusion for nausea and 
vomiting and delirium. Deep i.m depot inj (gluteal)  in form 
of haloperidol decanoate (oily) for long-term maintenance 
schizophrenia (where needed) dose 50-300 mg typically  
every 4 weeks
Dr Sharon Rees @reesprescribe 
Day 3: MOA #haloperidol: Antagonism of dopamine receptors 
(mainly D2) in brain reward and motivation pathways believed 
responsible for main effects; considered better for the 
positive symptoms of schizophrenia such as hallucinations/
aggression; less effective for negative symptoms such as 
apathy. #haloperidol also has role in palliative care as a 
potent anti-emetic (antagonises the D2 receptors in the CTZ) 
& management of restlessness/confusion (unlicenced). Some 
antagonism of ⍺1-receptors (possible effects re judgement, 
cognition) and 5HT2 (possible anti-hallucinogenic effect)
Dr Sharon Rees @reesprescribe 
Day 3 (cont): #haloperidol has higher affinity for D2 receptor  
than dopamine hence problematic ADR profile. As  
dopamine inhibits prolactin release, lower dopamine  
activity re #haloperidol use causes higher prolactin levels 
> breast enlargement, galactorrhoea,sexual dysfunction, 
menstrual irregularites
Dr Sharon Rees @reesprescribe 
Day 4: Kinetics #haloperidol; good oral bioavailability & high 
volume of distribution (crosses placenta/found breast milk). 
Liver metabolism mainly via CYP3A4/2D6 (polymorphisms 
relevant re response variation) & glucuronidation. Oral t½ 14-
36hr. Slow release depot forms peak concentration at 6 days, 
t½ 21 days
Dr Sharon Rees @reesprescribe 
Day 5: ADRs, common; agitation, somnolence, hyperkinesia, 
insomnia, weight change, tremor, tardive dyskinesia, dystonia, 
constipation, dry mouth. Rare/serious hyperprolactinaemia, 
neuroleptic malignant syndrome, agranulocytosis (not 
exhaustive). Planned and supported withdrawal important
Dr Sharon Rees @reesprescribe 
Day 5 (cont); Sudden death, QT-prolongation & Torsades de 
Pointes reported with #haloperidol especially with high doses. 
Potassium check at least once per year – monitoring also 
includes urea/electrolytes, FBG/HbA1c, prolactin levels, ECG 
before treatment and as appropriate during, LFTs, BMI, lipids
Dr Sharon Rees @reesprescribe 
Day 6: DDIs; #haloperidol has severe interactions with all 
drugs associated with QT prolongation such as amitriptyline. 
All drugs which lower K+ increase risk of torsades de pointes 
such as diuretics, prednisolone, salbutamol. Ritonavir 
increases exposure (not exhaustive). Avoid alcohol as 
hypotension and CNS depressant effects
Dr Sharon Rees @reesprescribe 
Day 7: Although #haloperidol is in the ‘low risk’ category for 
type 2 diabetes, all the anti-psychotics are obeseogenic drugs 
and are believed to have a direct effect on insulin resistance; 
screening and regular monitoring (at least annually) and 
lifestyle advice/support are important
Dr Sharon Rees 
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EARN YOUR CPD CERTIFICATE
With the help of Prescribing and Therapeutics Training Ltd and the Journal of Prescribing Practice,  
you can earn your 1-hour CPD certificate. 
Haloperidol is a second-generation anti-psychotic
TRUE or FALSE?
Haloperidol is licensed for use in children
TRUE or FALSE?
Which of the following is TRUE?
A. Haloperidol is used first-line to treat opioid dependence
B. Used as an i.v infusion for post-operative emesis
C. Doses are usually lowered in the elderly
D. Haloperidol was discovered in the 1970s
The major mechanism of action for haloperidol is antagonism of dopamine receptors  
in the brain
TRUE or FALSE?
Which of the following is TRUE?
A. Haloperidol affects all pituitary hormones including prolactin
B. Dopamine receptors in the pituitary gland modulate prolactin release, so dopamine 
antagonists such as haloperidol mean less restraint, more release
C. Dopaminergic pathways are enhanced by haloperidol and this encourages more 
prolactin release
D. Dopamine stimulates oestrogen and this switches on prolactin release
Tardive dyskinesia causes which of the following problems
A. Involuntary movements of the jaw, lips and tongue and sometimes limbs
B. Voluntary wave-like movements of the limbs
C. High velocity nystagmus
D. Muscle wasting 





An ECG is performed prior to haloperidol treatment because the anti-psychotics are 
obesogenic, so this is a baseline test to track cardiac stress while on the drug
TRUE or FALSE?
Haloperidol is a sedating anti-psychotic
TRUE or FALSE?









In addition to the tweets, read the 
BNF section on ‘psychoses and 
schizophrenia’ and the monograph on 
haloperidol. Another useful source is the 
summary of product characteristics for 
haloperidol, and then answer the nine 
questions. Please submit the answers to 
reesprescribe@gmail.com as a numbered 
list with TRUE/FALSE or the correct 
A,B,C,D option. If you achieve seven or 
more out of nine eight or more out of ten 
on the questions, a CPD certificate will be 
emailed to you.
Further reading on #haloperidol
 ● Haloperidol Injection BP 5mg/ml: https://
www.medicines.org.uk/emc/product/514/
smpc#PRODUCTINFO




 ● Monograph on Haloperidol: https://bnf.
nice.org.uk/drug/haloperidol.html
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Haloperidol Injection BP 5mg/ml. 2017. 
https://www.medicines.org.uk/emc/
product/514/smpc#PRODUCTINFO 
(accessed 20 August 2020) 
National Institute for Health and Care 
Excellence. Psychoses and related disorders. 
2020. https://bnf.nice.org.uk/treatment-
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